img

Global Biosynthesis of Cannabinoids Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Biosynthesis of Cannabinoids Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Cannabinoids are found in the cannabis plant, they can be produced in biosynthesis way. While biosynthesis has not yet proven itself as a scalable technology, it has the potential to radically alter the way cannabinoids are manufactured in the near future.These compounds are the exact same as what cannabis expresses.
Biosynthesis of Cannabinoids report published by MRA Research reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2023. Global Biosynthesis of Cannabinoids market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Demand from Food Industry and Medical Industry are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biosynthesis of Cannabinoids industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biosynthesis of Cannabinoids key companies include Anandia Laboratories, Gingko Bioworks, Hyasynth Bio, InMed Pharmaceuticals, Librede, Renew Biopharma, Cronos Group, Organigram and Teewinot Life Sciences, etc. Anandia Laboratories, Gingko Bioworks, Hyasynth Bio are top 3 players and held % share in total in 2023.
Biosynthesis of Cannabinoids can be divided into THC, CBD and Others,, etc. THC is the mainstream product in the market, accounting for % share globally in 2023.
Biosynthesis of Cannabinoids is widely used in various fields, such as Food Industry, Medical Industry and Others,, etc. Food Industry provides greatest supports to the Biosynthesis of Cannabinoids industry development. In 2023, global % share of Biosynthesis of Cannabinoids went into Food Industry filed.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biosynthesis of Cannabinoids market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Anandia Laboratories
Gingko Bioworks
Hyasynth Bio
InMed Pharmaceuticals
Librede
Renew Biopharma
Cronos Group
Organigram
Teewinot Life Sciences
ICC International Cannabis Corp.
Biotii Technologies Corp.
Bristol-Myers Squibb
Biogen Inc.
GW Pharmaceuticals
Segment by Type
THC
CBD
Others

Segment by Application


Food Industry
Medical Industry
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biosynthesis of Cannabinoids market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biosynthesis of Cannabinoids introduction, etc. Biosynthesis of Cannabinoids Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRA Research’s Conclusions of Biosynthesis of Cannabinoids market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRA Research.

Table of Content

1 Market Overview of Biosynthesis of Cannabinoids
1.1 Biosynthesis of Cannabinoids Market Overview
1.1.1 Biosynthesis of Cannabinoids Product Scope
1.1.2 Biosynthesis of Cannabinoids Market Status and Outlook
1.2 Global Biosynthesis of Cannabinoids Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global Biosynthesis of Cannabinoids Market Size by Region (2018-2033)
1.4 Global Biosynthesis of Cannabinoids Historic Market Size by Region (2018-2023)
1.5 Global Biosynthesis of Cannabinoids Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Biosynthesis of Cannabinoids Market Size (2018-2033)
1.6.1 North America Biosynthesis of Cannabinoids Market Size (2018-2033)
1.6.2 Europe Biosynthesis of Cannabinoids Market Size (2018-2033)
1.6.3 Asia-Pacific Biosynthesis of Cannabinoids Market Size (2018-2033)
1.6.4 Latin America Biosynthesis of Cannabinoids Market Size (2018-2033)
1.6.5 Middle East & Africa Biosynthesis of Cannabinoids Market Size (2018-2033)
2 Biosynthesis of Cannabinoids Market by Type
2.1 Introduction
2.1.1 THC
2.1.2 CBD
2.1.3 Others
2.2 Global Biosynthesis of Cannabinoids Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global Biosynthesis of Cannabinoids Historic Market Size by Type (2018-2023)
2.2.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Biosynthesis of Cannabinoids Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Biosynthesis of Cannabinoids Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Biosynthesis of Cannabinoids Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Biosynthesis of Cannabinoids Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Biosynthesis of Cannabinoids Revenue Breakdown by Type (2018-2033)
3 Biosynthesis of Cannabinoids Market Overview by Application
3.1 Introduction
3.1.1 Food Industry
3.1.2 Medical Industry
3.1.3 Others
3.2 Global Biosynthesis of Cannabinoids Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global Biosynthesis of Cannabinoids Historic Market Size by Application (2018-2023)
3.2.2 Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Biosynthesis of Cannabinoids Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Biosynthesis of Cannabinoids Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Biosynthesis of Cannabinoids Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Biosynthesis of Cannabinoids Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Biosynthesis of Cannabinoids Revenue Breakdown by Application (2018-2033)
4 Biosynthesis of Cannabinoids Competition Analysis by Players
4.1 Global Biosynthesis of Cannabinoids Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2023)
4.3 Date of Key Players Enter into Biosynthesis of Cannabinoids Market
4.4 Global Top Players Biosynthesis of Cannabinoids Headquarters and Area Served
4.5 Key Players Biosynthesis of Cannabinoids Product Solution and Service
4.6 Competitive Status
4.6.1 Biosynthesis of Cannabinoids Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Anandia Laboratories
5.1.1 Anandia Laboratories Profile
5.1.2 Anandia Laboratories Main Business
5.1.3 Anandia Laboratories Biosynthesis of Cannabinoids Products, Services and Solutions
5.1.4 Anandia Laboratories Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.1.5 Anandia Laboratories Recent Developments
5.2 Gingko Bioworks
5.2.1 Gingko Bioworks Profile
5.2.2 Gingko Bioworks Main Business
5.2.3 Gingko Bioworks Biosynthesis of Cannabinoids Products, Services and Solutions
5.2.4 Gingko Bioworks Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.2.5 Gingko Bioworks Recent Developments
5.3 Hyasynth Bio
5.3.1 Hyasynth Bio Profile
5.3.2 Hyasynth Bio Main Business
5.3.3 Hyasynth Bio Biosynthesis of Cannabinoids Products, Services and Solutions
5.3.4 Hyasynth Bio Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.3.5 InMed Pharmaceuticals Recent Developments
5.4 InMed Pharmaceuticals
5.4.1 InMed Pharmaceuticals Profile
5.4.2 InMed Pharmaceuticals Main Business
5.4.3 InMed Pharmaceuticals Biosynthesis of Cannabinoids Products, Services and Solutions
5.4.4 InMed Pharmaceuticals Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.4.5 InMed Pharmaceuticals Recent Developments
5.5 Librede
5.5.1 Librede Profile
5.5.2 Librede Main Business
5.5.3 Librede Biosynthesis of Cannabinoids Products, Services and Solutions
5.5.4 Librede Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.5.5 Librede Recent Developments
5.6 Renew Biopharma
5.6.1 Renew Biopharma Profile
5.6.2 Renew Biopharma Main Business
5.6.3 Renew Biopharma Biosynthesis of Cannabinoids Products, Services and Solutions
5.6.4 Renew Biopharma Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.6.5 Renew Biopharma Recent Developments
5.7 Cronos Group
5.7.1 Cronos Group Profile
5.7.2 Cronos Group Main Business
5.7.3 Cronos Group Biosynthesis of Cannabinoids Products, Services and Solutions
5.7.4 Cronos Group Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.7.5 Cronos Group Recent Developments
5.8 Organigram
5.8.1 Organigram Profile
5.8.2 Organigram Main Business
5.8.3 Organigram Biosynthesis of Cannabinoids Products, Services and Solutions
5.8.4 Organigram Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.8.5 Organigram Recent Developments
5.9 Teewinot Life Sciences
5.9.1 Teewinot Life Sciences Profile
5.9.2 Teewinot Life Sciences Main Business
5.9.3 Teewinot Life Sciences Biosynthesis of Cannabinoids Products, Services and Solutions
5.9.4 Teewinot Life Sciences Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.9.5 Teewinot Life Sciences Recent Developments
5.10 ICC International Cannabis Corp.
5.10.1 ICC International Cannabis Corp. Profile
5.10.2 ICC International Cannabis Corp. Main Business
5.10.3 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Products, Services and Solutions
5.10.4 ICC International Cannabis Corp. Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.10.5 ICC International Cannabis Corp. Recent Developments
5.11 Biotii Technologies Corp.
5.11.1 Biotii Technologies Corp. Profile
5.11.2 Biotii Technologies Corp. Main Business
5.11.3 Biotii Technologies Corp. Biosynthesis of Cannabinoids Products, Services and Solutions
5.11.4 Biotii Technologies Corp. Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.11.5 Biotii Technologies Corp. Recent Developments
5.12 Bristol-Myers Squibb
5.12.1 Bristol-Myers Squibb Profile
5.12.2 Bristol-Myers Squibb Main Business
5.12.3 Bristol-Myers Squibb Biosynthesis of Cannabinoids Products, Services and Solutions
5.12.4 Bristol-Myers Squibb Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.12.5 Bristol-Myers Squibb Recent Developments
5.13 Biogen Inc.
5.13.1 Biogen Inc. Profile
5.13.2 Biogen Inc. Main Business
5.13.3 Biogen Inc. Biosynthesis of Cannabinoids Products, Services and Solutions
5.13.4 Biogen Inc. Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.13.5 Biogen Inc. Recent Developments
5.14 GW Pharmaceuticals
5.14.1 GW Pharmaceuticals Profile
5.14.2 GW Pharmaceuticals Main Business
5.14.3 GW Pharmaceuticals Biosynthesis of Cannabinoids Products, Services and Solutions
5.14.4 GW Pharmaceuticals Biosynthesis of Cannabinoids Revenue (US$ Million) & (2018-2023)
5.14.5 GW Pharmaceuticals Recent Developments
6 North America
6.1 North America Biosynthesis of Cannabinoids Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biosynthesis of Cannabinoids Market Dynamics
11.1 Biosynthesis of Cannabinoids Industry Trends
11.2 Biosynthesis of Cannabinoids Market Drivers
11.3 Biosynthesis of Cannabinoids Market Challenges
11.4 Biosynthesis of Cannabinoids Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Biosynthesis of Cannabinoids Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Biosynthesis of Cannabinoids Market Size Share by Region (2018-2023)
Table 4. Global Biosynthesis of Cannabinoids Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Biosynthesis of Cannabinoids Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Biosynthesis of Cannabinoids Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global Biosynthesis of Cannabinoids Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2023)
Table 9. Global Biosynthesis of Cannabinoids Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Biosynthesis of Cannabinoids Revenue Market Share by Type (2024-2033)
Table 11. North America Biosynthesis of Cannabinoids Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Biosynthesis of Cannabinoids Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Biosynthesis of Cannabinoids Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Biosynthesis of Cannabinoids Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Biosynthesis of Cannabinoids Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Biosynthesis of Cannabinoids Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Biosynthesis of Cannabinoids Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Biosynthesis of Cannabinoids Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Biosynthesis of Cannabinoids Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Biosynthesis of Cannabinoids Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Biosynthesis of Cannabinoids Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global Biosynthesis of Cannabinoids Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Biosynthesis of Cannabinoids Revenue Market Share by Application (2018-2023)
Table 24. Global Biosynthesis of Cannabinoids Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Biosynthesis of Cannabinoids Revenue Market Share by Application (2024-2033)
Table 26. North America Biosynthesis of Cannabinoids Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Biosynthesis of Cannabinoids Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Biosynthesis of Cannabinoids Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Biosynthesis of Cannabinoids Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Biosynthesis of Cannabinoids Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Biosynthesis of Cannabinoids Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Biosynthesis of Cannabinoids Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Biosynthesis of Cannabinoids Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Biosynthesis of Cannabinoids Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Biosynthesis of Cannabinoids Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Biosynthesis of Cannabinoids Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Biosynthesis of Cannabinoids Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosynthesis of Cannabinoids as of 2023)
Table 39. Date of Key Players Enter into Biosynthesis of Cannabinoids Market
Table 40. Global Biosynthesis of Cannabinoids Key Players Headquarters and Area Served
Table 41. Biosynthesis of Cannabinoids Product Solution and Service
Table 42. Global Biosynthesis of Cannabinoids Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Anandia Laboratories Basic Information List
Table 45. Anandia Laboratories Description and Business Overview
Table 46. Anandia Laboratories Biosynthesis of Cannabinoids Products, Services and Solutions
Table 47. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Anandia Laboratories (2018-2023)
Table 48. Anandia Laboratories Recent Developments
Table 49. Gingko Bioworks Basic Information List
Table 50. Gingko Bioworks Description and Business Overview
Table 51. Gingko Bioworks Biosynthesis of Cannabinoids Products, Services and Solutions
Table 52. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Gingko Bioworks (2018-2023)
Table 53. Gingko Bioworks Recent Developments
Table 54. Hyasynth Bio Basic Information List
Table 55. Hyasynth Bio Description and Business Overview
Table 56. Hyasynth Bio Biosynthesis of Cannabinoids Products, Services and Solutions
Table 57. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Hyasynth Bio (2018-2023)
Table 58. Hyasynth Bio Recent Developments
Table 59. InMed Pharmaceuticals Basic Information List
Table 60. InMed Pharmaceuticals Description and Business Overview
Table 61. InMed Pharmaceuticals Biosynthesis of Cannabinoids Products, Services and Solutions
Table 62. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of InMed Pharmaceuticals (2018-2023)
Table 63. InMed Pharmaceuticals Recent Developments
Table 64. Librede Basic Information List
Table 65. Librede Description and Business Overview
Table 66. Librede Biosynthesis of Cannabinoids Products, Services and Solutions
Table 67. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Librede (2018-2023)
Table 68. Librede Recent Developments
Table 69. Renew Biopharma Basic Information List
Table 70. Renew Biopharma Description and Business Overview
Table 71. Renew Biopharma Biosynthesis of Cannabinoids Products, Services and Solutions
Table 72. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Renew Biopharma (2018-2023)
Table 73. Renew Biopharma Recent Developments
Table 74. Cronos Group Basic Information List
Table 75. Cronos Group Description and Business Overview
Table 76. Cronos Group Biosynthesis of Cannabinoids Products, Services and Solutions
Table 77. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Cronos Group (2018-2023)
Table 78. Cronos Group Recent Developments
Table 79. Organigram Basic Information List
Table 80. Organigram Description and Business Overview
Table 81. Organigram Biosynthesis of Cannabinoids Products, Services and Solutions
Table 82. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Organigram (2018-2023)
Table 83. Organigram Recent Developments
Table 84. Teewinot Life Sciences Basic Information List
Table 85. Teewinot Life Sciences Description and Business Overview
Table 86. Teewinot Life Sciences Biosynthesis of Cannabinoids Products, Services and Solutions
Table 87. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Teewinot Life Sciences (2018-2023)
Table 88. Teewinot Life Sciences Recent Developments
Table 89. ICC International Cannabis Corp. Basic Information List
Table 90. ICC International Cannabis Corp. Description and Business Overview
Table 91. ICC International Cannabis Corp. Biosynthesis of Cannabinoids Products, Services and Solutions
Table 92. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of ICC International Cannabis Corp. (2018-2023)
Table 93. ICC International Cannabis Corp. Recent Developments
Table 94. Biotii Technologies Corp. Basic Information List
Table 95. Biotii Technologies Corp. Description and Business Overview
Table 96. Biotii Technologies Corp. Biosynthesis of Cannabinoids Products, Services and Solutions
Table 97. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Biotii Technologies Corp. (2018-2023)
Table 98. Biotii Technologies Corp. Recent Developments
Table 99. Bristol-Myers Squibb Basic Information List
Table 100. Bristol-Myers Squibb Description and Business Overview
Table 101. Bristol-Myers Squibb Biosynthesis of Cannabinoids Products, Services and Solutions
Table 102. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Bristol-Myers Squibb (2018-2023)
Table 103. Bristol-Myers Squibb Recent Developments
Table 104. Biogen Inc. Basic Information List
Table 105. Biogen Inc. Description and Business Overview
Table 106. Biogen Inc. Biosynthesis of Cannabinoids Products, Services and Solutions
Table 107. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of Biogen Inc. (2018-2023)
Table 108. Biogen Inc. Recent Developments
Table 109. GW Pharmaceuticals Basic Information List
Table 110. GW Pharmaceuticals Description and Business Overview
Table 111. GW Pharmaceuticals Biosynthesis of Cannabinoids Products, Services and Solutions
Table 112. Revenue (US$ Million) in Biosynthesis of Cannabinoids Business of GW Pharmaceuticals (2018-2023)
Table 113. GW Pharmaceuticals Recent Developments
Table 114. North America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 115. North America Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 116. Europe Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 117. Europe Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 118. Asia-Pacific Biosynthesis of Cannabinoids Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 119. Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2018-2023) & (US$ Million)
Table 120. Asia-Pacific Biosynthesis of Cannabinoids Market Size by Region (2024-2033) & (US$ Million)
Table 121. Asia-Pacific Biosynthesis of Cannabinoids Market Share by Region (2018-2023)
Table 122. Asia-Pacific Biosynthesis of Cannabinoids Market Share by Region (2024-2033)
Table 123. Latin America Biosynthesis of Cannabinoids Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 124. Latin America Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 125. Latin America Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 126. Middle East & Africa Biosynthesis of Cannabinoids Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 127. Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2018-2023) & (US$ Million)
Table 128. Middle East & Africa Biosynthesis of Cannabinoids Market Size by Country (2024-2033) & (US$ Million)
Table 129. Biosynthesis of Cannabinoids Market Trends
Table 130. Biosynthesis of Cannabinoids Market Drivers
Table 131. Biosynthesis of Cannabinoids Market Challenges
Table 132. Biosynthesis of Cannabinoids Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biosynthesis of Cannabinoids Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Biosynthesis of Cannabinoids Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Biosynthesis of Cannabinoids Market Share by Regions: 2023 VS 2033
Figure 4. Global Biosynthesis of Cannabinoids Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Biosynthesis of Cannabinoids Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Biosynthesis of Cannabinoids Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Biosynthesis of Cannabinoids Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Biosynthesis of Cannabinoids Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Biosynthesis of Cannabinoids Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of THC
Figure 11. Global THC Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of CBD
Figure 13. Global CBD Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Global Biosynthesis of Cannabinoids Market Size Share by Type: 2023 & 2033
Figure 17. North America Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2033)
Figure 18. Europe Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2033)
Figure 19. Asia-Pacific Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2033)
Figure 20. Latin America Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2033)
Figure 21. Middle East and Africa Biosynthesis of Cannabinoids Revenue Market Share by Type (2018-2033)
Figure 22. Food Industry Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Medical Industry Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Global Biosynthesis of Cannabinoids Market Size Share by Application: 2023 & 2033
Figure 26. North America Biosynthesis of Cannabinoids Revenue Market Share by Application (2018-2033)
Figure 27. Europe Biosynthesis of Cannabinoids Revenue Market Share by Application (2018-2033)
Figure 28. Asia-Pacific Biosynthesis of Cannabinoids Revenue Market Share by Application (2018-2033)
Figure 29. Latin America Biosynthesis of Cannabinoids Revenue Market Share by Application (2018-2033)
Figure 30. Middle East and Africa Biosynthesis of Cannabinoids Revenue Market Share by Application (2018-2033)
Figure 31. Biosynthesis of Cannabinoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 32. Global Top 5 and Top 10 Players Biosynthesis of Cannabinoids Market Share in 2023
Figure 33. North America Biosynthesis of Cannabinoids Market Share by Country (2018-2033)
Figure 34. U.S. Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 35. Canada Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 36. Germany Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 37. France Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 38. U.K. Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 39. Italy Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 40. Russia Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 41. Nordic Countries Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Biosynthesis of Cannabinoids Market Share by Region (2018-2033)
Figure 43. China Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 44. Japan Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 45. South Korea Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 47. India Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 48. Australia Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 49. Latin America Biosynthesis of Cannabinoids Market Share by Country (2018-2033)
Figure 50. Mexico Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 51. Brazil Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Biosynthesis of Cannabinoids Market Share by Country (2018-2033)
Figure 53. Turkey Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 55. UAE Biosynthesis of Cannabinoids Market Size (2018-2033) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report